Nora Fritschi1, Axel J Schmidt2, Jürg Hammer3, Nicole Ritz1,4,5. 1. Department of Clinical Research, Mycobacterial and Migrant Health Research Group, University Children's Hospital Basel, University of Basel, Basel, Switzerland. 2. Infectious Diseases Division, Swiss Federal Office of Public Health, Bern, Switzerland. 3. Division of Respiratory and Critical Care Medicine, University Children's Hospital Basel, University of Basel, Basel, Switzerland. 4. Infectious Disease and Vaccinology Unit, University Children's Hospital Basel, University of Basel, Basel, Switzerland. 5. Department of Pediatrics, The Royal Children's Hospital Melbourne, The University of Melbourne, Parkville, Victoria, Australia.
Abstract
BACKGROUND: In Europe, surveillance and monitoring of pediatric tuberculosis (TB) remains important, particularly in the light of migration in recent years. The aim of the study was to evaluate incidence rates of childhood TB and detailed diagnostic pathways and treatment. METHODS: Data were collected through the Swiss Pediatric Surveillance Unit (SPSU) from December 2013 to November 2019. Monthly -notifications are obtained from the 33 pediatric hospitals in the SPSU, and a detailed questionnaire was sent out upon notification. Inclusion criteria were children and adolescents aged up to 15 years with culture- or molecular-confirmed TB disease or for whom a treatment with ≥3 antimycobacterial drugs had been initiated. Data were compared with age-matched notification data from the Swiss Federal Office of Public Health (FOPH). RESULTS: Of the 172 cases notified to SPSU, a detailed questionnaire was returned for 161 (93%) children, of which 139 met the inclusion criteria. Reasons for exclusion were age >15 years, double reporting, and not fulfilling the criteria for TB disease. During the same time period, 172 pediatric TB cases were reported to the FOPH, resulting in an incidence of 2.1 per 100,000, ranging from 1.4 to 2.8 per year, without a clear trend over time. In the 64 (46.0%) foreign-born children, incidence rates were higher and peaked in 2016, with 13.7 per 100,000 (p = 0.018). The median interval between arrival in Switzerland and TB diagnosis was 5 (IQR 1-21) months, and 80% were diagnosed within 24 months of arrival. In 58% of the cases, TB disease was confirmed by culture or molecular assays. Age >10 years, presence of fever, or weight loss were independent factors associated with confirmed TB. CONCLUSION: The annual pediatric TB incidence rate only varied among foreign-born children and was highest in 2016 when refugee influx peaked in Europe. Importantly, most foreign-born children with TB were diagnosed within 2 years after arrival in Switzerland. Thus, the early period after arrival in Switzerland is associated with a higher risk of TB disease in children, and this should be considered for screening guidance in refugees.
BACKGROUND: In Europe, surveillance and monitoring of pediatric tuberculosis (TB) remains important, particularly in the light of migration in recent years. The aim of the study was to evaluate incidence rates of childhood TB and detailed diagnostic pathways and treatment. METHODS: Data were collected through the Swiss Pediatric Surveillance Unit (SPSU) from December 2013 to November 2019. Monthly -notifications are obtained from the 33 pediatric hospitals in the SPSU, and a detailed questionnaire was sent out upon notification. Inclusion criteria were children and adolescents aged up to 15 years with culture- or molecular-confirmed TB disease or for whom a treatment with ≥3 antimycobacterial drugs had been initiated. Data were compared with age-matched notification data from the Swiss Federal Office of Public Health (FOPH). RESULTS: Of the 172 cases notified to SPSU, a detailed questionnaire was returned for 161 (93%) children, of which 139 met the inclusion criteria. Reasons for exclusion were age >15 years, double reporting, and not fulfilling the criteria for TB disease. During the same time period, 172 pediatric TB cases were reported to the FOPH, resulting in an incidence of 2.1 per 100,000, ranging from 1.4 to 2.8 per year, without a clear trend over time. In the 64 (46.0%) foreign-born children, incidence rates were higher and peaked in 2016, with 13.7 per 100,000 (p = 0.018). The median interval between arrival in Switzerland and TB diagnosis was 5 (IQR 1-21) months, and 80% were diagnosed within 24 months of arrival. In 58% of the cases, TB disease was confirmed by culture or molecular assays. Age >10 years, presence of fever, or weight loss were independent factors associated with confirmed TB. CONCLUSION: The annual pediatric TB incidence rate only varied among foreign-born children and was highest in 2016 when refugee influx peaked in Europe. Importantly, most foreign-born children with TB were diagnosed within 2 years after arrival in Switzerland. Thus, the early period after arrival in Switzerland is associated with a higher risk of TB disease in children, and this should be considered for screening guidance in refugees.
Authors: Luis E Cuevas; Renee Browning; Patrick Bossuyt; Martina Casenghi; Mark F Cotton; Andrea T Cruz; Lori E Dodd; Francis Drobniewski; Marianne Gale; Stephen M Graham; Malgosia Grzemska; Norbert Heinrich; Anneke C Hesseling; Robin Huebner; Patrick Jean-Philippe; Sushil Kumar Kabra; Beate Kampmann; Deborah Lewinsohn; Meijuan Li; Christian Lienhardt; Anna M Mandalakas; Ben J Marais; Heather J Menzies; Grace Montepiedra; Charles Mwansambo; Richard Oberhelman; Paul Palumbo; Estelle Russek-Cohen; David E Shapiro; Betsy Smith; Giselle Soto-Castellares; Jeffrey R Starke; Soumya Swaminathan; Claire Wingfield; Carol Worrell Journal: J Infect Dis Date: 2012-04-03 Impact factor: 5.226
Authors: Andrew R DiNardo; Anne Detjen; Pilar Ustero; Katherine Ngo; Jason Bacha; Anna M Mandalakas Journal: Tuberculosis (Edinb) Date: 2016-09-28 Impact factor: 3.131
Authors: Julia Brandenberger; Thorkild Tylleskär; Katrin Sontag; Bernadette Peterhans; Nicole Ritz Journal: BMC Public Health Date: 2019-06-14 Impact factor: 3.295
Authors: Jakub Klas; Aleksandra Grzywacz; Katarzyna Kulszo; Arkadiusz Grunwald; Natalia Kluz; Mikołaj Makaryczew; Marzena Samardakiewicz Journal: Int J Environ Res Public Health Date: 2022-08-26 Impact factor: 4.614